Sweden’s Sobi has announced that the European Commission (EC) has approved Aspaveli (pegcetacoplan) for adults and ...

Effective January1, 2026, STADA Arzneimitel’s global head of communications, Frank Staud, is additionally assuming global ...

WuXi XDC has made a bid to buy fellow Chinese firm BioDlink, a fully integrated CDMO offering end-to-end biologics ...

Italian non-profit organization Fondazione Telethon today announced the European Commission’s decision of January 9, to grant ...

As many as four decisions under the US Food and Drug Administration’s (FDA) new fast-track program have been delayed, Reuters ...

US biologics CDMO Avid Bioservices (Nasdaq: CDMO) has appointed Rich McAvoy as chief business officer, as the company talks ...

Russian customers are forced to save on drug purchases these days due to the ever-growing prices, falling incomes, and the ...

Japanese drugmaker Tanabe Pharma said its oral candidate dersimelagon met the primary endpoint and showed a favorable safety ...

Indian drug major Sun Pharmaceutical Industries yesterday announced that Unloxcyt (cosibelimab-ipdl) is now available in the ...

Eisai has reached a license agreement with Nuvation Bio, a global oncology company focused on tackling some of the toughest ...

President Donald Trump on Thursday unveiled what the White House calls the “Great Healthcare Plan,” an affordability-first ...

Diagnostics (iiDX), a company formed by the Infection Innovation Consortium, and Canadian biotech Eyam Health have launched a ...